首页|期刊导航|国际肝胆胰疾病杂志（英文版）|Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway

Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway

Jun-Liang Pu Zuo-Tian Huang Yun-Hai Luo Tong Mou Ting-Ting Li Zhong-Tang Li Xu-Fu Wei Zhong-Jun Wu

国际肝胆胰疾病杂志（英文版）2021，Vol.20Issue(4)：352-360,9.

Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway

Jun-Liang Pu ¹Zuo-Tian Huang ¹Yun-Hai Luo ¹Tong Mou ¹Ting-Ting Li ¹Zhong-Tang Li ²Xu-Fu Wei ¹Zhong-Jun Wu¹

作者信息

1. Department of Hepatobiliary Surgery,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China
2. Department of Anatomy,Basic Medical College,Chongqing Medical University,Chongqing 400016,China
折叠

摘要

关键词

Fisetin/Hepatic ischemia-reperfusion injury/GSK3β/AMPK/NLRP3

Key words

Fisetin/Hepatic ischemia-reperfusion injury/GSK3β/AMPK/NLRP3

引用本文复制引用

Jun-Liang Pu,Zuo-Tian Huang,Yun-Hai Luo,Tong Mou,Ting-Ting Li,Zhong-Tang Li,Xu-Fu Wei,Zhong-Jun Wu..Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway[J].国际肝胆胰疾病杂志（英文版）,2021,20(4):352-360,9.

基金项目

This study was supported by grants from the National Natural Science Foundation of China (81672959,81873592 and 81703063),the Science and Technology Commission Foundation of Chongqing,China (cstc2019jscx-gksbX0005),the Natural Science Foundation of Chongqing,China (cstc2018jscx-msybX0133) and the graduate tu-tor team construction project of Chongqing Municipal Education Commission Foundation,China (dstd201801). （81672959,81873592 and 81703063）

国际肝胆胰疾病杂志（英文版）

OACSCDSCI

ISSN：1499-3872

访问量0

下载量0

段落导航